Registry of Lobbyists

Monthly Communication Report

243-627281

Organization: CANADIAN CANCER SOCIETY/Société canadienne du cancer
Associated registration: 932742-243-91
Communication date: 2024-11-25
Posted date: 2024-12-16

Designated Public Office Holders who participated in the communication: Marcus Powlowski, Member of Parliament
House of Commons
 
List of Details
Subject matter Detail
Health Access to medication - expanding the range of medications covered by various insurance plans, and the number of Canadians able to access and afford medication. This includes a national pharmaceutical strategy.
Health, Research and Development Access to palliative care, as it relates to programs offered through Health Canada, Indigenous Services Canada, Immigration, Refugees, and Citizenship Canada, the Department of National Defence, and Employment and Social Development Canada.
Health Aging at Home Benefit.
Health Canada Health Act and regulations, as it relates to long-term, home and palliative care.
Budget, Employment and Training, Health, Taxation and Finance National Caregiving Strategy
Health Patent Act, as it relates to the use of patents for international humanitarian purposes to address public health problems.
Health Safe Long-Term Care Act.
 
Responsible Officer who filed this communication report: Andrea Seale
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Date Modified: